Nosocomial Infections (Hospital-Acquired Infections)

Nosocomial infections can be defined as an infection developed within a person during a stay in a hospital or any other healthcare facility.

To be precise, any infection developed in a person while receiving medical support in a health care setting, which was not present or was not in the incubation period prior to the admission of the person in the health care setting, is called nosocomial infection. To be a nosocomial infection, the disease must be developed only after at least 48 of admission to/visiting a healthcare facility.

It is also called ‘Hospital Acquired Infection (HAI)’ or ‘Healthcare Associated Infection (HCAI).’

The pathogens causing such infections are acquired during the process of receiving healthcare facilities in facilities like hospitals, nursing homes, clinics, diagnostic centers, rehabilitation centers, or any other clinical centers. The infection can develop and be noticed during the period of stay within such centers or may also be developed after discharge. 

The pathogens can be transmitted from any factors of the hospital environment (like air, water, bedding, building, wastes, etc.), hospital staff, medical devices, other patients, or any other objects. The pathogen may be the normal flora of the patient itself. During a hospital stay, if the immune system is compromised, the normal flora (opportunistic pathogens within or on the patient’s body) develops the infection. Such infections are also called nosocomial infections. If the incubation periods of such pathogens are shorter than the duration of hospital stay, the disease is observed during the period of stay within the hospital. However, if the incubation period is longer than the duration of the patient’s stay in the hospital, the disease is developed after the discharge of the patient. 

Types of Nosocomial Infections

The US Center for Disease Control and Prevention (CDC) categorizes nosocomial infections, broadly into the following 4 most frequent types:

Central Line-associated Bloodstream  Infection (CLABSI)

These are the bloodstream infections developed in patients with central venous catheters (catheters inserted in veins for administration of intravenous medications). It is common in patients in ICUs and is one of the major causes of HAI-associated morbidity and mortality globally; with about 12 to 25% mortality rate in the USA in 2020. 

Catheter-associated Urinary Tract Infection (CAUTI)

These are urinary tract infections (infections developed in the urinary tract) in persons with indwelling urinary catheters. It is the most common form of HAIs and is the prime cause of secondary bloodstream infections. A major case of complicated UTI cases is associated with urinary catheterization. 

Surgical Site Infections (SSI)

These are the infections developed in or around the site where surgery was done within 30 days of surgery. The infection can be superficial or limited to the epidermal layer (Superficial SSI), deep beneath the incision area in muscle (Deep Incisional SSI), or infecting inner organs (Space SSI).   

Ventilator-associated Pneumonia (VAP)

Pneumonia is the second most common nosocomial infection after UTI seen in patients with critical illness and the associated mortality rate may be up to 50%. If a patient receiving mechanical ventilator support develops pneumonia after 48 hours of being incubated, then pneumonia can be defined as ventilator-associated pneumonia. 

Besides, there are other types of nosocomial infections, viz.:

Gastroenteritis/Gastrointestinal Infections

Gastrointestinal infections seen in patients after at least 48 hours of admission, during their stay in the healthcare facility, or within 3 days of being discharged from the healthcare facility can be defined as nosocomial gastroenteritis. 

Nosocomial Skin Infection

Infection of the skin due to exposure to pathogenic microorganisms in a healthcare facility is called nosocomial skin infection.  After a long hospital stay or use of antimicrobials and/or other medications making the immune system weak, the normal skin flora of the patients begins to develop several forms of skin infections like rashes, ulcers, cellulitis, folliculitis, pyogenic and non-pyogenic wounds, etc. The most common causative is Staphylococcus spp.; either normal flora or Staph transmitted from other patients or most commonly healthcare workers.  

Non-catheter-associated Bloodstream Infections and Urinary Tract Infections

These are bloodstream infections and urinary tract infections seen in hospitalized (including recently discharged) patients without any catheterization. 

Non-ventilator-associated Pneumonia (NVAP)and other Respiratory Tract Infections

In hospitalized patients without ventilator support, several forms of respiratory tract infections are seen; all these RTIs fall under this category. While VAP is associated primarily with aerobes, the non-ventilator-associated RTIs are caused by aerobes, anaerobes, as well as respiratory viruses.

Nosocomial infections can also be classified on the basis of associated pathogenic microorganisms into bacterial, fungal, and viral nosocomial infections. 

Risk Factors

The common risk factors associated with the development of nosocomial infections are listed below: 

1. Immunocompromisation 

Patients with immune-compromised conditions due to any disease or administration of medical products are likely to develop nosocomial infections more often than patients with healthy/functional immune systems. 

2. Invasive Medical Procedures including Catheterization 

Invasive medical procedures like surgery, catheterization, angioplasty, medical device insertion, thrombectomy, coronary stenting, etc. increase the risk of the introduction of pathogens directly into the dermal or muscular region escaping the primary layer of defense, the skin. This will make the patent more prone to the development of infections. Similarly, medical devices allow the route of administration of pathogens and also allow for biofilm formation; hence, increasing the chance of infection.

3. Prolonged Use of Antimicrobials 

Prolonged use of antimicrobials will inhibit normal flora, allowing colonization of other pathogenic organisms from the environment. Similarly, some antimicrobials also tend to weaken the immune system increasing the chance of infection. 

4. Prolonged Hospitalization 

Prolonged hospitalization increases the risk of exposure to pathogens increasing the chance of acquiring nosocomial infection. 

5. Use of Contaminated Medical Devices 

Medical devices like thermometers, pulse-oximeter, sphygmomanometers, etc. are used for multiple patients without sterilization. This will also increase the risk of transmission of pathogens. 

6. Contact with other Patients and Career Medical Personals 

Pathogens from other patients and medical personnel can be transmitted to susceptible patients visiting healthcare settings. 

7. Chronic Diseases 

Chronic diseases like HIV, COPD, cancer, etc. make a person more susceptible to nosocomial infection. 

8. Age

Age is also a major factor influencing the chance of acquiring HCAIs. Elderly people and neonates are more susceptible than children and adults. 

Epidemiology of Nosocomial Infections

These types of infections are reported globally and can occur in any healthcare setting. In general, about 10% of admitted persons are reported to be infected with a type of hospital-acquired infection. Among the hospital-admitted patients, patients in intensive care units (ICU), burn units, and surgical or post-surgical wards suffer from HAIs. 

The prevalence rate is a little higher in developing countries than in developed countries. In high-income (developed) countries about 7 in 100 i.e. 7% and 15 in 100 i.e. 15% of patients admitted to acute health care services are infected with at least one nosocomial infection. Among HAI-acquired patients, about 10% will die from the infection; hence, it is one of the major causes of mortality and morbidity in healthcare settings. The date is, however, different in different regions/countries. There is no regular study done on this topic in every country, so the exact rate of prevalence is difficult to determine.  The US CDC reports that about 3.2% of hospitalized patients in the USA develop at least one nosocomial infection. 

Common Pathogens Responsible for Nosocomial Infections

Bacterial infections are the most common types of nosocomial infections followed by fungal and viral infections. Parasitic infections are rarely encountered; hence they contribute a negligible portion of nosocomial infections. 

Bacterial Pathogens 

They are the most common types of microorganisms causing HCAIs. Both opportunistic and true pathogenic bacteria cause HCAIs. Some common bacterial pathogens associated with nosocomial infections are:

Fungal Pathogens

Fungi account for most of the HCAIs after bacteria. They mainly infect severely immunocompromised patients, patients with severe granulocytopenia, and ventilated patients. Some common fungal pathogens associated with nosocomial infections are:

Candida spp. (Candida albicans, fluconazole resistant C. krusei, C. glabrata) 

Aspergillus spp. (A. fumigatus, A. flavus) 

Mucorales (Mucor spp.)

Fusarium spp. 

Pneumocystis jirovecii

Scedosporium spp. 

Malassezia spp. 

Acremonium spp. 

Viral Pathogens

Several viruses are responsible for a minor portion of nosocomial infections. Some common viruses causing nosocomial infections are:

Noroviruses

Rotaviruses

Influenza viruses

Respiratory syncytial virus

Herpes Simplex Virus

Hepatitis B and C virus

Common Nosocomial Infections and Associated Risk Factors and Pathogens

Common Source/Reservoir of Pathogens Associated with Nosocomial Infections

1. Healthcare setting staff (including both clinical and non-clinical personnel) 
2. Environmental aspects like surface, water, food, air, patient room, bathroom, basin, bedding, door knobs, medical devices, etc.
3. Patients (normal flora of patients themselves or microbiome from other patients) 
4. Visiting members of patients 
5. Hospital wastes   
6. Animals like pests, insects, and others in the healthcare facility 

Common Transmission Route of Nosocomial Infections

1. Contact transmission: Direct contact with patients or healthcare workers or contact with contaminated surfaces and equipment. 
2. Droplet transmission: From infectious respiratory droplets produced during coughing, sneezing, speaking, etc., or during medical procedures.
3. Airborne transmission: Infectious agents can transmit over long distances via contaminated air. 
4. Fecal-oral transmission: Fecal-contaminated food and water ingestion can also transmit nosocomial infections. 
5. Vector transmission: Vectors such as insects and rodents can spread pathogens in healthcare settings. 
6. Vehicle Transmission: The vehicle includes food, water, medical devices, syringes, PPEs, body fluid-contaminated materials, etc. 

Impact of Nosocomial Infection on Patients

• Increased morbidity and mortality rate

HCAIs make the case worse and/or cause secondary infections and increase the morbidity and mortality rate of patients. 

• Prolonged hospital stay

The nosocomial infections will increase the severity of the case demanding prolonged hospital stays and more medicines for treatment. 

• Chance of antimicrobial-resistant infections

Nosocomial infections are often caused by antimicrobial-resistant species transmitted from hospital settings. Hospitalized patients are often administered antibiotics which can induce the development of antimicrobial resistance in patient-associated microorganisms.  

• The increased cost of treatment 

Increased case morbidity and antimicrobial-resistant infections demand prolonged hospital stays and more medicines for treatment which will increase the cost of treatment. 

Antibiotic Resistance and Nosocomial Infections 

Healthcare settings are the primary source of origin and dissemination of antimicrobial-resistant species because they are the place where antimicrobials are mainly used and pathogens from different sources are accumulated. Many pathogens causing HCAIs are found to be antimicrobial-resistant strains and the cases of antimicrobial-resistant associated HCAIs are increasing rapidly across the globe.  

ESKAPE is a group of multi-drug resistant pathogenic bacteria, mostly responsible for nosocomial infections. This group includes 6 pathogens, viz. Enterococcus faecium (Vancomycin Resistant Enterococcus faecium), Staphylococcus aureus (MRSA and VRSA), Klebsiella pneumoniae (Carbapenem resistant Klebsiella pneumoniae (CRKP)), Acinetobacter baumannii (Carbapenem resistant Acinetobacter baumannii (CRAB)), Pseudomonas aeruginosa (Carbapenem resistant Pseudomonas aeruginosa (CRPA)), and Enterobacter spp. (Pan-drug resistant Enterobacter spp.).  Besides, Beta-lactamase producing Enterobacterales, drug-resistant Candida spp., and other fungal pathogens, drug-resistant Streptococcus spp. are also serious threats to nosocomial infections. 

These AMR pathogens increase the chance of HCAIs, case severity, prolonged hospital stay, increased cost of treatment, and higher mortality. 

Prevention, Control, and Management of Nosocomial Infections 

For the prevention, control, and management of nosocomial infections, the following measures should be adopted.

1. The practice of good hand hygiene– Healthcare workers should practice good hand hygiene like washing with soap and water, use of gloves, or use of hand sanitizers before and after visiting a patient. Similarly, the family person visiting or taking care of the patients must follow hand hygiene. This will reduce the transmission of pathogens from healthcare workers to patients. 
2. Proper and regular sanitization of hospital setting– Healthcare settings including patient rooms, beddings, equipment, surfaces, etc. must be regularly disinfected and cleaned. 
3. Regular monitoring and surveillance of the hospital environment for any potential pathogens is necessary. The data from such a program will allow the infection control department to make effective plans to prevent and control nosocomial infections.
4. Patient isolation– Patients with infectious diseases and patients with higher susceptibility to infections must be isolated.
5. Antimicrobial stewardship can help to reduce the probability of emergence/development and spread of AMR pathogens. 
6. Use of PPE (personal protective equipment)– PPE like globes, masks, goggles, aprons, body suits, etc. is very important to prevent the transmission of pathogens in healthcare facilities. Healthcare workers must use PPE so that they can prevent acquiring and transmitting pathogens from one patient to another. Patients must also use general PPE like masks and gloves during their stay and visit to healthcare facilities.
7. Immunization can play a very important role in developing immunity against possible HCAIs. 
8. Educating healthcare workers/staff regarding HCAIs, their mode of transmission, and methods to prevent such diseases can be a very effective method to prevent and control the spread of HCAIs in a healthcare facility.   
9. Minimize the hospital visit and hospital stay duration if possible, because prolonged hospital stay will increase the risk of being infected with HCAIs.    
10. Proper management of hospital wastes and proper pest control is also very important to prevent the emergence and spread of infection in hospitals. 
11. Ensuring proper implication of strategies and plans to prevent and control HCAIs is also very important.

References

1. WHO launches first-ever global report on infection prevention and control
2. Centers for Disease Control and Prevention. (2019). National and state healthcare-associated infection prevalence and incidence data. https://www.cdc.gov/hai/data/index.html
3. Toor, H., Farr, S., Savla, P., Kashyap, S., Wang, S., & Miulli, D. E. (2022). Prevalence of Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care and Medical-Surgical Units. Cureus, 14(3). https://doi.org/10.7759/cureus.22809
4. Monegro AF, Muppidi V, Regunath H. Hospital Acquired Infections. [Updated 2023 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441857/
5. Bell, T. (2017). Prevention of Central Line-Associated Bloodstream Infections. Infectious disease clinics of North America, 31(3), 551. https://doi.org/10.1016/j.idc.2017.05.007
6. Werneburg, G. T. (2022). Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Research and Reports in Urology, 14, 109-133. https://doi.org/10.2147/RRU.S273663
7. Nicolle, L.E. Catheter associated urinary tract infections. Antimicrob Resist Infect Control 3, 23 (2014). https://doi.org/10.1186/2047-2994-3-23
8. C.D. Owens; K. Stoessel (2008). Surgical site infections: epidemiology, microbiology and prevention. , 70(supp-S2), 3–10. doi:10.1016/s0195-6701(08)60017-1
9. Kohbodi GNA, Rajasurya V, Noor A. Ventilator-associated Pneumonia. [Updated 2022 Sep 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507711/
10. Koenig, S. M., & Truwit, J. D. (2006). Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clinical Microbiology Reviews, 19(4), 637-657. https://doi.org/10.1128/CMR.00051-05
11. Lam BC, Tam J, Ng MH, Yeung CY. Nosocomial gastroenteritis in paediatric patients. J Hosp Infect. 1989 Nov;14(4):351-5. doi: 10.1016/0195-6701(89)90075-3. PMID: 2575634.
12. Moreira, Licia L. RN; Netto, Eduardo M. MD, PhD; Nascimento-Carvalho, Cristiana M. MD, PhD. Nosocomial Gastroenteritis in Children With and Without Rotavirus Infection. The Pediatric Infectious Disease Journal 28(1):p 72, January 2009. | DOI: 10.1097/INF.0b013e31818ec288
13. Gutierrez, M. B., Fialho, A. M., Cantelli, C. P., Miagostovich, M. P., & Fumian, T. M. (2021). Nosocomial acute gastroenteritis outbreak caused by an equine-like G3P[8] DS-1-like rotavirus and GII.4 Sydney[P16] norovirus at a pediatric hospital in Rio de Janeiro, Brazil, 2019. Human Vaccines & Immunotherapeutics, 17(11), 4654-4660. https://doi.org/10.1080/21645515.2021.1963169
14. Sikora A, Zahra F. Nosocomial Infections. [Updated 2023 Jan 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559312/
15. American Thoracic Society. (2016). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Retrieved from https://www.atsjournals.org/doi/pdf/10.1164/rccm.201603-0593ST
16. Munro SC, Baker D, Giuliano KK, Sullivan SC, Haber J, Jones BE, Crist MB, Nelson RE, Carey E, Lounsbury O, Lucatorto M, Miller R, Pauley B, Klompas M. Nonventilator hospital-acquired pneumonia: A call to action. Infect Control Hosp Epidemiol. 2021 Aug;42(8):991-996. doi: 10.1017/ice.2021.239. Epub 2021 Jun 9. PMID: 34103108.
17. Donkor, E. S. (2019). Nosocomial Pathogens: An In-Depth Analysis of the Vectorial Potential of Cockroaches. Tropical Medicine and Infectious Disease, 4(1). https://doi.org/10.3390/tropicalmed4010014
18. Suleyman G, and Alangaden GJ. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. Infect Dis Clin North Am 2021; 35(4):1027-1053.
19. Joshua Perlroth, Bryan Choi, Brad Spellberg, Nosocomial fungal infections: epidemiology, diagnosis, and treatment, Medical Mycology, Volume 45, Issue 4, June 2007, Pages 321–346, https://doi.org/10.1080/13693780701218689
20. SCOTT K. FRIDKIN AND CLINICALMICROBIOLOGYREVIEWS, Oct. 1996, p. 499–511Vol. 9, No. 40893-8512/96/$04.0010 Copyright 1996. WILLIAM R. JARVIS. American Society for Microbiology. https://doi.org/10.1128/CMR.9.4.499
21. Wright SA, Bieluch VM. Selected nosocomial viral infections. Heart Lung. 1993 Mar-Apr;22(2):183-7. PMID: 8449764.
22. Aitken, C., & Jeffries, D. J. (2001). Nosocomial Spread of Viral Disease. Clinical Microbiology Reviews, 14(3), 528-546. https://doi.org/10.1128/CMR.14.3.528-546.2001
23. Soltani R, Khorvash F, Pazandeh F. Antimicrobial Resistance Pattern of Nosocomial Infections at a Referral Teaching Hospital. J Pharm Care. 2020;8(1):26-34.
24. Schaberg, D. R., Rubens, C. E., Alford, R. H., Farrar, W., Schaffner, W., & McGee, Z. A. (1981). Evolution of antimicrobial resistance and nosocomial infection: Lessons from the vanderbilt experience. The American Journal of Medicine, 70(2), 445-448. https://doi.org/10.1016/0002-9343(81)90786-5
25. Avershina, E., Shapovalova, V., & Shipulin, G. (2021). Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.707330
26. Hormozi, S. F., Vasei, N., Aminianfar, M., Darvishi, M., & Saeedi, A. A. (2018). Antibiotic resistance in patients suffering from nosocomial infections in Besat Hospital. European Journal of Translational Myology, 28(3). https://doi.org/10.4081/ejtm.2018.7594
27. Nimer, N. A. (2022). Nosocomial Infection and Antibiotic-Resistant Threat in the Middle East. Infection and Drug Resistance, 15, 631-639. https://doi.org/10.2147/IDR.S351755
28. Lachassinne E, Letamendia-Richard E, Gaudelus J. Epidémiologie des infections nosocomiales en néonatalogie [Epidemiology of nosocomial infections in neonates]. Arch Pediatr. 2004 Mar;11(3):229-33. French. doi: 10.1016/j.arcped.2003.10.016. PMID: 15049286; PMCID: PMC7133330.
29. Nakamura RK, Tompkins E. Nosocomial infections. Compend Contin Educ Vet. 2012 Apr;34(4):E1-10; quiz E11. PMID: 22488599.
30. Olaechea PM, Insausti J, Blanco A, Luque P. Epidemiología e impacto de las infecciones nosocomiales [Epidemiology and impact of nosocomial infections]. Med Intensiva. 2010 May;34(4):256-67. Spanish. doi: 10.1016/j.medin.2009.11.013. Epub 2010 Jan 21. PMID: 20096484.
31. Khan, H. A., Baig, F. K., & Mehboob, R. (2017). Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pacific Journal of Tropical Biomedicine, 7(5), 478-482. https://doi.org/10.1016/j.apjtb.2017.01.019
32. Ken Inweregbu, BSc FRCA, Jayshree Dave, MSc MRC Path MD MBA, Alison Pittard, FRCA, Nosocomial infections, Continuing Education in Anaesthesia Critical Care & Pain, Volume 5, Issue 1, February 2005, Pages 14–17, https://doi.org/10.1093/bjaceaccp/mki006
33. Benedetta Allegranzi; Sepideh Bagheri Nejad; Christophe Combescure; Wilco Graafmans; Homa Attar; Liam Donaldson; Didier Pittet (2011). Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. , 377(9761), 0–241. doi:10.1016/s0140-6736(10)61458-4
34. Weber, D. J., & Rutala, W. A. (2013). Understanding and preventing transmissions of healthcare-associated pathogens due to the contaminated hospital environment. Infection control and hospital epidemiology, 34(5), 449-452.
35. The burden of health care-associated infection worldwide (who.int)
36. Nosocomial infection: What is it, types, and more (medicalnewstoday.com)
37. https://www.hopkinsmedicine.org/health/conditions-and-diseases/surgical-site-infections
38. Healthcare-Associated Infections (HAIs) | HAI | CDC
39. 10 Common Hospital-acquired Infections | HowStuffWorks
40. Nosocomial infection | definition of nosocomial infection by Medical dictionary (thefreedictionary.com)
41. Nosocomial Infections – Causes, Symptoms, Diagnosis and Treatment (medic-journal.com)
42. Preventing Healthcare-associated Infections | HAI | CDC
43. Types of Healthcare-associated Infections | HAI | CDC
44. MDRO Guides | HAI | CDC
45. Nosocomial Infection: What Is It? (webmd.com)
46. Hospital-acquired infection. (2023, April 17). In Wikipedia. https://en.wikipedia.org/wiki/Hospital-acquired_infection